Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Adobe
ADBE
|
$454M |
| 2 |
CRH
CRH
|
$432M |
| 3 |
Broadcom
AVGO
|
$427M |
| 4 |
Philip Morris
PM
|
$398M |
| 5 |
Kenvue
KVUE
|
$301M |
Top Sells
| 1 |
Exxon Mobil
XOM
|
$475M |
| 2 |
Microsoft
MSFT
|
$472M |
| 3 |
Visa
V
|
$414M |
| 4 |
Merck
MRK
|
$384M |
| 5 |
Meta Platforms (Facebook)
META
|
$380M |
Sector Composition
| 1 | Technology | 21.92% |
| 2 | Healthcare | 11.83% |
| 3 | Financials | 11.72% |
| 4 | Industrials | 11.17% |
| 5 | Consumer Discretionary | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Telefonica
TEF
$30.2B
| $43.3K | ﹤0.01% |
+10,647
| New | +$43.3K |
|
3652
BRC Inc
BRCC
$176M
| $43.1K | ﹤0.01% |
11,996
| – | – |
|
3653
Atara Biotherapeutics
ATRA
$86.7M
| $42.9K | ﹤0.01% |
28,998
+140
| +0.5% | +$207 |
|
3654
HF Foods Group
HFFG
$180M
| $41.6K | ﹤0.01% |
10,480
| – | – |
|
3655
Nomura Holdings
NMR
$21B
| $41.5K | ﹤0.01% |
10,322
-6,785
| -40% | -$27.3K |
|
3656
Verrica Pharmaceuticals
VRCA
$52.8M
| $41.4K | ﹤0.01% |
10,660
| – | – |
|
3657
Cue Biopharma
CUE
$60M
| $40.6K | ﹤0.01% |
17,646
| – | – |
|
3658
Cidara Therapeutics
CDTX
$1.66B
| $39.8K | ﹤0.01% |
42,223
+17,207
| +69% | +$16.2K |
|
|
CAMP
3659
DELISTED
CalAmp Corp.
CAMP
| $36.6K | ﹤0.01% |
90,300
+720
| +0.8% | +$292 |
|
|
WE
3660
DELISTED
WeWork Inc.
WE
| $36.1K | ﹤0.01% |
11,988
-463,677
| -97% | -$1.4M |
|
|
ADAP
3661
Adaptimmune Therapeutics
ADAP
$15.3M
| $35.8K | ﹤0.01% |
45,906
+10,914
| +31% | +$8.51K |
|
3662
Workhorse Group
WKHS
$19.8M
| $35.2K | ﹤0.01% |
84,957
+1,669
| +2% | +$692 |
|
3663
Trevi Therapeutics
TRVI
$885M
| $35K | ﹤0.01% |
16,046
| – | – |
|
|
AMRN
3664
Amarin Corp
AMRN
$311M
| $35K | ﹤0.01% |
38,017
+3,346
| +10% | +$3.08K |
|
3665
Redwire
RDW
$1.28B
| $34.4K | ﹤0.01% |
11,907
| – | – |
|
3666
Citius Pharmaceuticals
CTXR
$22.6M
| $33.6K | ﹤0.01% |
49,049
| – | – |
|
3667
Hitek Global
HKIT
$43.4M
| $32.5K | ﹤0.01% |
+14,081
| New | +$32.5K |
|
3668
Vor Biopharma
VOR
$258M
| $30.8K | ﹤0.01% |
14,523
| – | – |
|
3669
Ocugen
OCGN
$322M
| $30.7K | ﹤0.01% |
76,797
+3,548
| +5% | +$1.42K |
|
|
NGM
3670
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $30.5K | ﹤0.01% |
28,522
+5,589
| +24% | +$5.98K |
|
3671
BioAtla
BCAB
$26.7M
| $30.4K | ﹤0.01% |
17,857
+53
| +0.3% | +$90 |
|
|
VXRT
3672
DELISTED
Vaxart
VXRT
| $30.3K | ﹤0.01% |
40,247
+12,975
| +48% | +$9.78K |
|
|
VAXX
3673
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
| $29.8K | ﹤0.01% |
21,761
| – | – |
|
|
GTHX
3674
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $29.8K | ﹤0.01% |
20,697
+6,772
| +49% | +$9.75K |
|
3675
Beyond Air
XAIR
$11.6M
| $29.3K | ﹤0.01% |
12,676
| – | – |
|